Sanofi
Top Ten most popular articles on Pharmafile.com this week
September 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten
It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …
Sanofi and Regeneron’s projected blockbuster gains EU approval
September 28, 2017Sales and Marketing Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …
Sanofi’s arthritis treatment Kevzara secures NICE recommendation
September 25, 2017Sales and Marketing Kevzara, NICE, Sanofi, pharma, pharmaceutical, rheumatoid arthritis, sarilumab
Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its …
Alnylam soars on likely first RNAi treatment approval
September 22, 2017Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical
Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …
New therapy offers triple threat to HIV virus
September 22, 2017Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
Sanofi/Regeneron new asthma data bolstered by potential indications
September 13, 2017Research and Development Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and Regeneron’s Dupixent is predicted to grow to be one of the largest selling drugs in the industry but …
Sanofi backs out of controversial Zika vaccine project
September 4, 2017Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical
Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …
EVP of Diabetes decamps from Sanofi to become Almirall CEO
August 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
Strong Q2 growth for Sanofi raises 2017 sales outlook
July 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dupixient, Sanofi, biotech, drugs, healthcare, pharma, pharmaceuticals
Sanofi exuded renewed confidence in its updated forecast for 2017 on the back of a Q2 report which illustrated strong …
Department of Health appoints Teva and Sanofi veteran as commercial head
July 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, Sanofi, Teva, biotech, drugs, government, healthcare, pharma, pharmaceuticals
The UK Government has announced a new appointment within the Department of Health: Steve Oldfield, a former veteran of Teva …
Sanofi Pasteur Korea appoint new General Manager
July 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Sanofi Pasteur, biotech, drugs, pharma, pharmaceutical
Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …
MSD’s Lantus biosimilar given conditional FDA approval
July 21, 2017Medical Communications, Sales and Marketing FDA, MSD, Sanofi, biosimilar, biotech, drugs, pharma, pharmaceutical
MSD, known as Merck in North America, has been granted approval for its biosimilar of Sanofi’s diabetes treatment, Lantus. Potentially, …
Sanofi makes moves with strategic $2.4 billion Ablynx nanobody deal
July 20, 2017Sales and Marketing Ablynx, Sanofi, biotech, drugs, nanobody, pharma, pharmaceutical
Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech …
Sanofi snatches up Protein Sciences for $750 million
July 11, 2017Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, acquisition, protein sciences
French drug maker Sanofi has announced that it has agreed to acquire vaccine biotech company Protein Sciences for a potential …
Revealing the missing evidence: Randomised real-life studies in basal insulin therapy
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data
Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …
